Recent advance in mesenchymal stem cells therapy for atopic dermatitis |
| |
| Authors: | Jonathan Najera Jijun Hao |
| |
| Institution: | 1. College of Veterinary Medicine, Western University of Health Sciences, Pomona, California, USA
Department of Biology, College of Science, California State University Polytechnic University, Pomona, California, USA;2. College of Veterinary Medicine, Western University of Health Sciences, Pomona, California, USA |
| |
| Abstract: | Mesenchymal stem cells (MSCs) are multipotent cells found in a variety of tissues in the body, including but not limited to bone marrow, adipose tissue, umbilical cord, and umbilical cord blood. Given their immunomodulatory effect and ability to be readily isolated from several tissues, they have great potential to be used as a therapeutic agent in a variety of immune-mediated disorders. Atopic dermatitis (AD) is a persistent and relapsing immune skin condition that has recently become more common in several species such as humans, canines, equines, and felines. The use of MSCs to treat AD has piqued the great interest of researchers in recent years. In this article, we review the recent understanding of AD pathology and advances in preclinical and clinical studies of MSCs, MSCs-derived conditional media and exosomes as therapeutic tools to treat AD. |
| |
| Keywords: | atopic dermatitis conditional media exosomes inflammatory skin diseases mesenchymal stem cells |
|
|
